Propofol opioïd interaction
Engbers, F.
Acta Anaesthesiologica Belgica 48(4): 223-227
1997
ISSN/ISBN: 0001-5164 PMID: 9526599 Document Number: 483781
Document emailed within 1 workday
Related Documents
Kaye, A.D.; Chung, K.S.; Vadivelu, N.; Cantemir, C.; Urman, R.D.; Manchikanti, L. 2014: Opioid induced hyperalgesia altered with propofol infusion Pain Physician 17(2): E225-E228Vuyk, J. 2001: Clinical interpretation of pharmacokinetic and pharmacodynamic propofol-opioid interactions Acta Anaesthesiologica Belgica 52(4): 445-451
Rónai, A.Z.; Botyánszki, J.; Magyar, A.; Borsodi, A.; Benyhe, S.; Medzihradszky, K. 1993: Novel, delta-opioid receptor-selective peptide antagonists: demonstration of a possible opioid interaction in the absence of a protonated nitrogen and attempts to locate the protonated nitrogen site Archives Internationales de Pharmacodynamie et de Therapie 323: 114-125
Iarygin, K.N.; Ankudinova, O.N.; Kotin, A.M. 1991: Interaction of tetrahydroisoquinolines and 3-aminotetralines with opioid mu-receptors Bioorganicheskaia Khimiia 17(9): 1172-1176
Rong, S.B.; Jiang, H.L.; Chi, Z.Q.; Chen, K.X.; Zhu, Y.C.; Ji, R.Y. 1997: Molecular modeling of interaction between delta opioid receptor and 3-methylfentanylisothiocyanate Zhongguo Yao Li Xue Bao 18(3): 219-224
Hustveit, O.; Maurset, A.; Oye, I. 1995: Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors Pharmacology and Toxicology 77(6): 355-359
Rhee, H.M.; Tyler, L. 1985: Interaction of adrenergic and opioid systems in the short-term regulation of cardiovascular activities Canadian Journal of Cardiology 1(6): 395-400
Presl, J.; Bukovský, A. 1986: Interaction of endogenous opioid peptides, thymus hormones and immunocytes--relation to ovarian function Ceskoslovenska Gynekologie 51(6): 436-447
De Castro-e-Silva, E.; Antunes-Rodrigues, J. 1988: Evidence for interaction between central beta-2 adrenoceptors and epinephrine pathways in the opioid-induced prolactin rise in the rat Brazilian Journal of Medical and Biological Research 21(5): 1057-1063
Verberne, A.J.; Louis, W.J. 1989: Interaction between the cardiovascular effects of clonidine and the kappa-opioid agonist U-50,488H in the anterior hypothalamic area of the rat brain Journal of Pharmacy and Pharmacology 41(2): 131-133
Guglietta, A.; Irons, B.J.; Lazarus, L.H.; de Castiglione, R.; Melchiorri, P. 1989: Dimeric dermorphin peptides: central administration suppresses gastric acid secretion through interaction with mu-type opioid receptor Methods and Findings in Experimental and Clinical Pharmacology 11(11): 663-670
Rong, S.B.; Zhu, Y.C.; Jiang, H.L.; Zhao, S.R.; Wang, Q.M.; Chi, Z.Q.; Chen, K.X.; Ji, R.Y. 1997: Molecular modeling of mu opioid receptor and receptor-ligand interaction Zhongguo Yao Li Xue Bao 18(4): 317-322
Olmos, M.; Guijarrubia, E.G.; Maestro, B.; Ballester, J.A.; Vidarte, M.A. 1998: Treatment of the hypertensive response during coronary surgery: comparison of high-dose propofol to propofol with nitroprusside Revista Espanola de Anestesiologia y Reanimacion 45(8): 326-332
Nieuwenhuijs, D.; Sarton, E.; Teppema, L.J.; Kruyt, E.; Olievier, I.; van Kleef, J.; Dahan, A. 2001: Respiratory sites of action of propofol: absence of depression of peripheral chemoreflex loop by low-dose propofol Anesthesiology 95(4): 889-895
Krobbuaban, B.; Diregpoke, S.; Kumkeaw, S.; Tanomsat, M. 2005: Comparison on pain on injection of a small particle size-lipid emulsion of propofol and standard propofol with or without lidocaine Journal of the Medical Association of Thailand 88(10): 1401-1405
Sundarathiti, P.; Boonthom, N.; Chalacheewa, T.; Jommaroeng, P.; Rungsithiwan, W. 2007: A comparison of propofol-LCT with propofol-LCT/MCT on pain of injection Journal of the Medical Association of Thailand 90(12): 2683-2688
Lewis, J.W.; Cannon, J.T.; Stapleton, J.M.; Liebeskind, J.C. 1980: Stress activates endogenous pain-inhibitory systems: opioid and non-opioid mechanisms Proceedings of the Western Pharmacology Society 23: 85-88
Drennan, I.R.; Orkin, A.M. 2016: OPIOID CRISIS. Prehospital naloxone administration for opioid-related emergencies Jems: a Journal of Emergency Medical Services 41(3): 36-39
Krupitskiĭ, E.M. 2014: Injectable extended-release naltrexone for the prevention of relapse to opioid dependence following opioid detoxification Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(5 Pt 2): 64-72
Zimmerman, D.M.; Leander, J.D.; Reel, J.K.; Hynes, M.D. 1987: Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands Journal of Pharmacology and Experimental Therapeutics 241(2): 374-378